Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors
Ji Zhou(Wannan Medical College), Chao Zhang(Wannan Medical College), Lizhen Yu(Wannan Medical College), Ci-Hao Guo(Wannan Medical College), Shengpeng Zhang(Wannan Medical College), Pingping Zhao(China Pharmaceutical University), Weihua Hu(Wannan Medical College), Dong‐Dong Miao(Wannan Medical College), Xiaoping Liu(Lakehead University), Xinyu Li(China Pharmaceutical University), Zhiyin Zhou(Wannan Medical College), Xiaomei Lv(Zhejiang University), Yali Fan(Capital Medical University), Huidan Huang(Wannan Medical College)
Cited by 19
Related Papers
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for improved isoprene production in Saccharomyces cerevisiae
|Nature Communications|2016|256
The Semen pH Affects Sperm Motility and Capacitation
|PLoS ONE|2015|159
Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR pathway to prevent cervical cancer
|Journal of Ethnopharmacology|2024|142
Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
|Frontiers in Cell and Developmental Biology|2021|80